134 related articles for article (PubMed ID: 36894259)
1. It Doesn't Smell Like Cancer to Me: The Promise of Exhaled Breath Biomarkers for Lung Cancer Diagnosis.
Kammer MN; Paez R
Chest; 2023 Mar; 163(3):479-480. PubMed ID: 36894259
[No Abstract] [Full Text] [Related]
2. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
Zhou J; Huang ZA; Kumar U; Chen DDY
Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
[TBL] [Abstract][Full Text] [Related]
3. Exhaled breath condensate biomarkers for lung cancer.
Campanella A; De Summa S; Tommasi S
J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387
[TBL] [Abstract][Full Text] [Related]
4. Progress in the development of volatile exhaled breath signatures of lung cancer.
Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
[TBL] [Abstract][Full Text] [Related]
5. Exhaled biomarkers in lung cancer.
Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
[TBL] [Abstract][Full Text] [Related]
6. Influence of Sensory Stimulation on Exhaled Volatile Organic Compounds.
Mazzatenta A; Pokorski M; Di Tano A; Cacchio M; Di Giulio C
Adv Exp Med Biol; 2016; 884():75-9. PubMed ID: 26453064
[TBL] [Abstract][Full Text] [Related]
7. Exhaled Aldehydes as Biomarkers for Lung Diseases: A Narrative Review.
Floss MA; Fink T; Maurer F; Volk T; Kreuer S; Müller-Wirtz LM
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014494
[TBL] [Abstract][Full Text] [Related]
8. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer biomarkers in exhaled breath.
Amann A; Corradi M; Mazzone P; Mutti A
Expert Rev Mol Diagn; 2011 Mar; 11(2):207-17. PubMed ID: 21405971
[TBL] [Abstract][Full Text] [Related]
10. Breath testing as a method for detecting lung cancer.
Taivans I; Bukovskis M; Strazda G; Jurka N
Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
[TBL] [Abstract][Full Text] [Related]
11. High performance exhaled breath biomarkers for diagnosis of lung cancer and potential biomarkers for classification of lung cancer.
Long Y; Wang C; Wang T; Li W; Dai W; Xie S; Tian Y; Liu M; Liu Y; Peng X; Liu Y; Zhang Y; Wang R; Li Q; Duan Y
J Breath Res; 2021 Feb; 15(1):016017. PubMed ID: 33586667
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of exhaled carbonyl compounds distinguishes benign from malignant pulmonary disease.
Bousamra M; Schumer E; Li M; Knipp RJ; Nantz MH; van Berkel V; Fu XA
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1074-80; discussion 1080-1. PubMed ID: 25129599
[TBL] [Abstract][Full Text] [Related]
13. [Measurement of exhaled volatile organic compounds in lung cancer patients].
Lu CR; Hu YJ; Chen EG; Qiu YH; Ying KJ
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):104-8. PubMed ID: 20367949
[TBL] [Abstract][Full Text] [Related]
14. Breath profile as composite biomarkers for lung cancer diagnosis.
Zou Y; Wang Y; Jiang Z; Zhou Y; Chen Y; Hu Y; Jiang G; Xie D
Lung Cancer; 2021 Apr; 154():206-213. PubMed ID: 33563485
[TBL] [Abstract][Full Text] [Related]
15. A Metal Oxide Gas Sensors Array for Lung Cancer Diagnosis Through Exhaled Breath Analysis.
Marzorati D; Mainardi L; Sedda G; Gasparri R; Spaggiari L; Cerveri P
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():1584-1587. PubMed ID: 31946198
[TBL] [Abstract][Full Text] [Related]
16. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
17. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis by Volatile Organic Compounds in Exhaled Breath from Lung Cancer Patients Using Support Vector Machine Algorithm.
Sakumura Y; Koyama Y; Tokutake H; Hida T; Sato K; Itoh T; Akamatsu T; Shin W
Sensors (Basel); 2017 Feb; 17(2):. PubMed ID: 28165388
[TBL] [Abstract][Full Text] [Related]
19. Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening.
Boedeker E; Friedel G; Walles T
Interact Cardiovasc Thorac Surg; 2012 May; 14(5):511-5. PubMed ID: 22345057
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.
Kort S; Brusse-Keizer M; Schouwink H; Citgez E; de Jongh FH; van Putten JWG; van den Borne B; Kastelijn EA; Stolz D; Schuurbiers M; van den Heuvel MM; van Geffen WH; van der Palen J
Chest; 2023 Mar; 163(3):697-706. PubMed ID: 36243060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
